Literature DB >> 17332882

The role of CXC chemokines in pulmonary fibrosis.

Robert M Strieter1, Brigitte N Gomperts, Michael P Keane.   

Abstract

The CXC chemokine family is a pleiotropic family of cytokines that are involved in promoting the trafficking of various leukocytes, in regulating angiogenesis and vascular remodeling, and in promoting the mobilization and trafficking of mesenchymal progenitor cells such as fibrocytes. These functions of CXC chemokines are important in the pathogenesis of pulmonary fibrosis and other fibroproliferative disorders. In this Review, we discuss the biology of CXC chemokine family members, specifically as it relates to their role in regulating vascular remodeling and trafficking of circulating mesenchymal progenitor cells (also known as fibrocytes) in pulmonary fibrosis.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17332882      PMCID： PMC1804376          DOI： 10.1172/JCI30562

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


  103 in total

1.  Cxc chemokine receptor expression on human endothelial cells.

Authors:  C Murdoch; P N Monk; A Finn
Journal:  Cytokine       Date:  1999-09       Impact factor: 3.861

2.  The acute respiratory distress syndrome: fibrosis in the fast lane.

Authors:  R Marshall; G Bellingan; G Laurent
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

3.  [Neovascularization of tumors. New therapeutic possibilities].

Authors:  E L Lund; P E Kristjansen
Journal:  Ugeskr Laeger       Date:  1999-05-17

4.  Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis.

Authors:  M P Keane; J A Belperio; T A Moore; B B Moore; D A Arenberg; R E Smith; M D Burdick; S L Kunkel; R M Strieter
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

5.  Segmental vascular resistance in postobstructive pulmonary vasculopathy.

Authors:  R P Michel; T S Hakim; D Petsikas
Journal:  J Appl Physiol (1985)       Date:  1990-09

Review 6.  Assays for angiogenesis: a review.

Authors:  R Auerbach; W Auerbach; I Polakowski
Journal:  Pharmacol Ther       Date:  1991       Impact factor: 12.310

7.  Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha.

Authors:  R Salcedo; K Wasserman; H A Young; M C Grimm; O M Howard; M R Anver; H K Kleinman; W J Murphy; J J Oppenheim
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

Review 8.  Possible mechanisms of bleomycin-induced fibrosis.

Authors:  D B Chandler
Journal:  Clin Chest Med       Date:  1990-03       Impact factor: 2.878

9.  Neoformation of blood vessels in association with rat lung fibrosis induced by bleomycin.

Authors:  M N Peão; A P Aguas; C M de Sá; N R Grande
Journal:  Anat Rec       Date:  1994-01

10.  Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization.

Authors:  M Loetscher; P Loetscher; N Brass; E Meese; B Moser
Journal:  Eur J Immunol       Date:  1998-11       Impact factor: 5.532
View more
  107 in total

1.  Negative regulation of lung inflammation and immunopathology by TNF-α during acute influenza infection.

Authors:  Daniela Damjanovic; Maziar Divangahi; Kapilan Kugathasan; Cherrie-Lee Small; Anna Zganiacz; Earl G Brown; Cory M Hogaboam; Jack Gauldie; Zhou Xing
Journal:  Am J Pathol       Date:  2011-10-14       Impact factor: 4.307

Review 2.  Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases.

Authors:  Thomas A Wynn
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

Review 3.  Anti-fibrogenic strategies and the regression of fibrosis.

Authors:  Tatiana Kisseleva; David A Brenner
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-04       Impact factor: 3.043

4.  Photobiomodulation therapy improves both inflammatory and fibrotic parameters in experimental model of lung fibrosis in mice.

Authors:  Robson Alexandre Brochetti; Mayara Peres Leal; Raíssa Rodrigues; Renata Kelly da Palma; Luis Vicente Franco de Oliveira; Anna Carolina Ratto Tempestini Horliana; Amílcar Sabino Damazo; Ana Paula Ligeiro de Oliveira; Rodolfo Paula Vieira; Adriana Lino-Dos-Santos-Franco
Journal:  Lasers Med Sci       Date:  2017-07-16       Impact factor: 3.161

5.  Characterization of Quin-C1 for its anti-inflammatory property in a mouse model of bleomycin-induced lung injury.

Authors:  Min He; Ni Cheng; Wei-wei Gao; Meng Zhang; Yue-yun Zhang; Richard D Ye; Ming-wei Wang
Journal:  Acta Pharmacol Sin       Date:  2011-04-18       Impact factor: 6.150

6.  What differentiates normal lung repair and fibrosis? Inflammation, resolution of repair, and fibrosis.

Authors:  Robert M Strieter
Journal:  Proc Am Thorac Soc       Date:  2008-04-15

Review 7.  Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy.

Authors:  Yao Wang; Terry J Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-20       Impact factor: 4.799

8.  Circulating progenitor cells in chronic lung disease.

Authors:  Borna Mehrad; Michael P Keane; Brigitte N Gomperts; Robert M Strieter
Journal:  Expert Rev Respir Med       Date:  2007-08       Impact factor: 3.772

9.  Dynamic Regulation of Integrin α6β4 During Angiogenesis: Potential Implications for Pathogenic Wound Healing.

Authors:  Diana Desai; Purva Singh; Livingston Van De Water; Susan E Laflamme
Journal:  Adv Wound Care (New Rochelle)       Date:  2013-10       Impact factor: 4.730

10.  Pten inactivation accelerates oncogenic K-ras-initiated tumorigenesis in a mouse model of lung cancer.

Authors:  Kentaro Iwanaga; Yanan Yang; Maria Gabriela Raso; Lijiang Ma; Amy E Hanna; Nishan Thilaganathan; Seyed Moghaddam; Christopher M Evans; Huaiguang Li; Wei-Wen Cai; Mitsuo Sato; John D Minna; Hong Wu; Chad J Creighton; Francesco J Demayo; Ignacio I Wistuba; Jonathan M Kurie
Journal:  Cancer Res       Date:  2008-02-15       Impact factor: 12.701
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.